Epidural Block vs. Rectus Sheath Block on Postoperative Pulmonary Function

June 6, 2018 updated by: Mansoura University

Effect of Thoracic Epidural Analgesia vs Rectus Sheath Catheters on Postoperative Pulmonary Function After Midline Laparotomy: A Prospective Randomized Controlled Study

Pulmonary complications are among the most important postoperative complications after midline incisions, for which different analgesic modalities have been tried.

Epidural analgesia is the recommended technique to relieve pain after major abdominal surgery owing to the proved superior analgesia, reduction of opioid related side effects as nausea, vomiting, pruritis and sedation, earlier recovery of bowel function and earlier ability for postoperative mobility However, it is not without complications.

Rectus sheath block provides several advantages over epidural anesthesia. It lessens the potential risks associated with neuraxial techniques, so it may represent a novel alternative approach for somatic analgesia after major abdominal surgeries. Although patients with rectus sheath block may experience some visceral pain, it is usually minimal by 24 hours after surgery.

Study Overview

Detailed Description

The aim of this study is to compare the effects of thoracic epidural analgesia and rectus sheath blockade on postoperative pulmonary functions, pain scores, duration of analgesia, sedation scores, patients' satisfaction and adverse effects.

FEV1, FEV1/FVC ratio will be measured by a bed side spirometer.

  • Induction of anesthesia: propofol 1.5-2.5 mg kg-1.
  • Muscle Relaxants: rocuronium 0.6 mg kg-1 for induction.
  • Maintenance: Sevoflurane 0.7-1.5 MAC vaporized in air-oxygen (40% inspired fraction).

Radial artery catheterization: under complete aseptic conditions 20G cannula will be inserted into the radial artery of non-dominant hand after performing modified Allen's test and local infiltration of 0.5ml xylocaine 2% .

Thoracic epidural catheter will be inserted before induction of general anaesthesia under aseptic insertion conditions and using loss of resistance to air technique with the patient in the sitting position at T9- T11 interspaces.

The Rectus sheath catheters will be inserted bilaterally using ultrasound (SonoSite M-Turbo®, Sonosite , USA) guidance as described by Webster after induction of general anaesthesia.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DK
      • Mansourah, DK, Egypt, 050
        • Mansoura University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anesthesiologists physical class I to III.
  • Patients scheduled for elective midline laparotomy.

Exclusion Criteria:

  • Morbid obese patients.
  • Severe or uncompensated cardiovascular disease.
  • Significant renal disease.
  • Significant hepatic disease.
  • Pregnancy.
  • Lactating.
  • Allergy to the study medications.
  • Psychological disorder.
  • Neurological disorder.
  • Communication barrier.
  • Mental disorders.
  • Epilepsy.
  • FEV1 or FEV1/FVC ratio less than 50%, dyspnea with a New York Heart Association class IV.
  • Drug or alcohol abuse.
  • Contraindications to epidural anaesthesia.
  • Opioid analgesic medication within 24 h before the operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Thoracic epidural analgesia (TEA)
Patients who will be subjected for midline laparotomy, will receive epidural analgesia through an inserted thoracic epidural catheter before induction of general anesthesia
Epidural catheter will be inserted at T9-T11. Then, epidural analgesia will be activated with administering bolus of 10 mls 0.25% bupivacaine in conjunction with100 mcg fentanyl to establish a block. This will be followed by an infusion of 0.125% bupivacaine in conjunction with 2 mcg/ ml fentanyl at a rate of 10 mls /hour and then titrated to effect for up to 48 hour postoperative
ACTIVE_COMPARATOR: Rectus sheath catheter block
After insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected on each side, then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.
Following insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected through each one. Then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in forced expiratory volume in 1 second (FEV1)
Time Frame: Before and for 72 hours after surgery
Before and for 72 hours after surgery
Changes in ratio between forced expiratory volume in 1 s and forced vital capacity (FEV1/FVC)
Time Frame: Before and for 72 hours after surgery
Before and for 72 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in arterial blood gases
Time Frame: Before and for 72 hours after surgery
Before and for 72 hours after surgery
Visual analog pain scores
Time Frame: for 48 hours after surgery
Postoperative pain will be assessed on rest and with cough and during movements for both of visceral and parietal pain
for 48 hours after surgery
Sedation score
Time Frame: for 48 hours after surgery
Sedation scores using a sedation scale (awake and alert= 0; quietly awake= 1; asleep but easily roused= 2; deep sleep= 3.
for 48 hours after surgery
Postoperative nausea and vomiting
Time Frame: for 48 hours after surgery
The degree of nausea and vomiting. Nausea will be measured using a numerical rating system (none= 0; mild= 1; moderate= 2; severe= 3). The number of vomiting episodes and the number of anti-emetics received
for 48 hours after surgery
Return of bowel function
Time Frame: for 72 hours after surgery
The times to first flatus, defecation, intake of clear liquid and solid food tolerance
for 72 hours after surgery
Time to hospital discharge
Time Frame: for 15 days after surgery
from the end of anesthesia
for 15 days after surgery
Cumulative tramadol use
Time Frame: For 48 hours after surgery
For 48 hours after surgery
Overall patient's satisfaction
Time Frame: For 48 hours after surgery
Patient overall satisfaction will be assessed before hospital discharge using the visual analog score
For 48 hours after surgery
Intraoperative use of ephedrine
Time Frame: For 5 hours after induction of anesthesia
For 5 hours after induction of anesthesia
Postoperative cardio-respiratory complications
Time Frame: For 7 days after surgery
For 7 days after surgery
Postoperative wound infection
Time Frame: For 21 days after surgery
For 21 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2017

Primary Completion (ACTUAL)

May 1, 2018

Study Completion (ACTUAL)

May 1, 2018

Study Registration Dates

First Submitted

January 16, 2016

First Submitted That Met QC Criteria

January 16, 2016

First Posted (ESTIMATE)

January 21, 2016

Study Record Updates

Last Update Posted (ACTUAL)

June 8, 2018

Last Update Submitted That Met QC Criteria

June 6, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • R ∕ 15.12.48

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Surgeries

Clinical Trials on Thoracic epidural analgesia (TEA)

Subscribe